Abstract
We observed in a study of 7,651 patients with acute coronary syndromes that a white blood cell (WBC) count of > 10,000 was associated with increased 30-day and 10-month mortality (6.2% vs 3.2% to 3.6% for WBC count < 10,000; p < 0.000). With its simplicity and widespread availability, WBC count could serve as a simple, inexpensive, new tool for risk stratification in acute coronary syndromes.
Publication types
-
Clinical Trial
-
Comparative Study
-
Multicenter Study
-
Randomized Controlled Trial
MeSH terms
-
Aged
-
Alanine / administration & dosage
-
Angina, Unstable / drug therapy
-
Angina, Unstable / immunology
-
Angina, Unstable / mortality*
-
Female
-
Follow-Up Studies
-
Humans
-
Leukocyte Count*
-
Male
-
Middle Aged
-
Myocardial Infarction / drug therapy
-
Myocardial Infarction / immunology
-
Myocardial Infarction / mortality*
-
Platelet Aggregation Inhibitors / administration & dosage
-
Pyrrolidines / administration & dosage
-
Risk Factors
-
Survival Rate
Substances
-
Platelet Aggregation Inhibitors
-
Pyrrolidines
-
orbofiban
-
Alanine